|
"whang peng j"的相關文件
顯示項目 151-200 / 215 (共5頁)
<< < 1 2 3 4 5 > >>
每頁顯示[10|25|50]項目
| 國家衛生研究院 |
2004-09 |
Current status of clinical studies for colorectal cancer in Taiwan
|
Chen, L;Whang-Peng, J |
| 國家衛生研究院 |
2004-09 |
Advantages of assaying telomerase activity in ascites for diagnosis of digestive tract malignancies
|
Li, C;Huang, T;Chao, Y;Chang, F;Whang-Peng, J;Lee, S |
| 國家衛生研究院 |
2004-07 |
Impact of severe acute respiratory syndrome on the status of lung cancer chemotherapy patients and a correlation of the signs and symptoms
|
Chen, YM; Perng, RP; Chu, H; Tsai, CM; Whang-Peng, J |
| 國家衛生研究院 |
2004-07 |
Preliminary report of a randomized trial of different docetaxel schedules in non-small cell lung cancer patients failing previous chemotherapy
|
Chen, YM;Shih, JF;Tsai, CM;Perng, RP;Whang-Peng, J |
| 國家衛生研究院 |
2004-04-15 |
Generation of carcinoembryonic antigen (CEA)-specific T-cell responses in HLA-A*0201 and HLA-A*2402 late-stage colorectal cancer patients after vaccination with dendritic cells loaded with CEA peptides
|
Liu, KJ; Wang, CC; Chen, LT; Cheng, AL; Lin, DT; Wu, YC; Yu, WL; Hung, YM; Yang, HY; Juang, SH; Whang-Peng, J |
| 中國醫藥大學 |
2004-04 |
Generation of CEA-specific T-cell response in HLA-A*0201 and HLA-A*2402 late-stage colorectal cancer patients following vaccination with dendritic cells loaded with CEA peptides.
|
(Liu, K.-J.*); (Wang, C.-C.); (Chen, L.-T.); (Cheng, A.-L.); (Lin, D.-T.); (Wu, Y.-C.); (Yu, W.-L); (Hung, Y.-M.); 莊聲宏(Shin-Hun Juang); (Whang-Peng, J) |
| 國家衛生研究院 |
2004-03 |
Randomized clinical trial of morbidity after D1 and D3 surgery for gastric cancer
|
Wu, CW; Hsiung, CA; Lo, SS; Hsieh, MC; Shia, LT; Whang-Peng, J |
| 國家衛生研究院 |
2004-02-26 |
A randomised phase II study of weekly paclitaxel or vinorelbine in combination with cisplatin against inoperable non-small-cell lung cancer previously untreated
|
Chen, YM; Perng, RP; Shih, JF; Lee, YC; Lee, CS; Tsai, CM; Whang-Peng, J |
| 國家衛生研究院 |
2004-02 |
Concurrent delivery of tumor antigens and activation signals to dendritic cells by irradiated CD40 ligand-transfected tumor cells resulted in efficient activation of specific CD8(+) T cells
|
Liu, KJ; Lu, LF; Cheng, HT; Hung, YM; Shiou, SR; Whang-Peng, J; Juang, SH |
| 中國醫藥大學 |
2004-02 |
Concurrent delivery of tumor antigens and activation signals to dendritic cells by irradiated CD40 ligand-transfected tumor cells resulted in efficient activation of specific CD8+ T cells
|
(Liu K.-J*)*; (Lu L.-F.); (Cheng H.-T.); (Hung Y.-M.); (Shiou S.-R.); (Whang-Peng J); 莊聲宏(Shin-Hun Juang) |
| 國家衛生研究院 |
2004-01 |
A G-quadruplex ligand 3,3 '-diethyloxadicarbocyanine iodide induces mitochondrion-mediated apoptosis but not decrease of telomerase activity in nasopharyngeal carcinoma NPC-TW01 cells
|
Li, CP; Huang, JH; Chang, AC; Hung, YM; Lin, CH; Chao, Y; Lee, SD; Whang-Peng, J; Huang, TS |
| 臺北醫學大學 |
2004 |
Randomized clinical trial of morbidity after D1 and D3 surgery for gastric cancer.
|
謝茂志; Wu CW; Hsiung CA; Lo SS; Hsieh MC; Shia LT; Whang-Peng J |
| 高雄醫學大學 |
2004 |
台灣大腸直腸癌臨床研究之現況
|
陳立宗;彭汪嘉康 ; Chen LT;Whang-Peng J. |
| 高雄醫學大學 |
2004 |
Generation of carcinoembryonic antigen (CEA)-specific T-cell responses in HLA-A0201 and HLA-A2402 late-stage colorectal cancer patients after vaccination with dendritic cells loaded with CEA peptides.
|
陳立宗; Liu KJ;Wang CC;Chen LT;Cheng AL;Lin DT;Wu YC;Yu WL;Hung YM;Yang HY;Juang SH;Whang-Peng J. |
| 國家衛生研究院 |
2003-12 |
Phase II study of gemcitabine and vinorelbine combination chemotherapy in patients with non-small-cell lung cancer not responding to previous chemotherapy
|
Chen, YM; Perng, RP; Lee, CS; Lin, WC; Tsai, CM; Whang-Peng, J |
| 國家衛生研究院 |
2003-12 |
Spider angiomas in patients with liver cirrhosis: Role of vascular endothelial growth factor and basic fibroblast growth factor
|
Li, CP; Lee, FY; Hwang, SJ; Lu, RH; Lee, WP; Chao, Y; Wang, SS; Chang, FY; Whang-Peng, J; Lee, SD |
| 國家衛生研究院 |
2003-06 |
Steroid-free chemotherapy decreases risk of hepatitis B virus (HBV) reactivation in HBV-carriers with lymphoma
|
Cheng, AL; Hsiung, CA; Su, IJ; Chen, PJ; Chang, MC; Tsao, CJ; Kao, WY; Uen, WC; Hsu, CH; Tien, HF; Chao, TY; Chen, LT; Whang-Peng, J |
| 國家衛生研究院 |
2003-05 |
A phase II trial of vinorelbine plus gemcitabine in previously untreated inoperable (stage IIIb/IV) non-small-cell lung cancer patients aged 80 or older
|
Chen, YM; Perng, RP; Chen, MC; Tsai, CM; Liu, JM; Whang-Peng, J |
| 國家衛生研究院 |
2003-01-24 |
Shortening of microsatellite deoxy(CA) repeats involved in GL331-induced down-regulation of matrix metalloproteinase-9 gene expression
|
Huang, TS; Lee, CC; Chang, AC; Lin, S; Chao, CC; Jou, YS; Chu, YW; Wu, CW; Whang-Peng, J |
| 高雄醫學大學 |
2003 |
Steroid-free chemotherapy decreases risk of hepatitis B virus (HBV) reactivation in HBV-carriers with lymphoma
|
鄭安理;陳立宗;彭汪嘉康 ; Cheng AL;Hsiung CA;Su IJ;Chen PJ;Chang MC;Tsao CJ;Kao WY;Uen WC;Hsu CH;Tien HF;Chao TY;Chen LT;Whang-Peng J |
| 國家衛生研究院 |
2002-10 |
Phase II study of docetaxel and gemcitabine combination chemotherapy in non-small-cell lung cancer patients failing previous chemotherapy
|
Chen, YM; Perng, RP; Lin, WC; Wu, HW; Tsai, CM; Whang-Peng, J |
| 國家衛生研究院 |
2002-10 |
Double signal stimulation was required for full recovery of the autologous tumor-killing effect of effusion-associated lymphocytes
|
Chen, YM; Tsai, CM; Whang-Peng, J; Perng, RP |
| 中國醫藥大學 |
2002-09-19 |
Irradiated CD40 ligand-transfected tumor cells efficiently deliver tumor antigens and activation signals to dendritic cells and promote the growth of CD8+ T cells in vitro.
|
(Liu, K.-J.)*; (Lu, L.-F.); (Cheng, H.-T.); (Hung, Y.-M.); (Shiou, S.-R.); (Whang-Peng, J); 莊聲宏(Shin-Hun Juang) |
| 國家衛生研究院 |
2002-08 |
Expression of epidermal growth factor receptor in head and neck cancers correlates with clinical progression: a multicentre immunohistochemical study in the Asia-Pacific region
|
Putti, TC; To, KF; Hsu, HC; Chan, ATC; Lai, GM; Tse, G; Lee, YS; Whang-Peng, J; Millward, M; Lin, L; Lin, X; Lee, CS |
| 國家衛生研究院 |
2002-07 |
Non-surgical treatment for afferent loop syndrome in recurrent gastric cancer complicated by peritoneal carcinomatosis: percutaneous transhepatic duodenal drainage followed by 24-hour infusion of high-dose fluorouracil and leucovorin
|
Lee, KD; Liu, TW; Wu, CW; Tiu, CM; Liu, JM; Chung, TR; Chang, JY; Whang-Peng, J; Chen, LT |
| 國家衛生研究院 |
2002-07 |
Palliative meflep therapy in advanced pancreatic cancer: Excellent response in a patient with her-2/neu amplification
|
Chao, Y;Liu, JM;YauLi, AF;Perng, CL;Tiu, CM;King, KL;Chen, LT;Lin, WC;Lan, C;Whang-Peng, J |
| 國家衛生研究院 |
2002-05 |
Phase II and pharmacokinetic study of GL331 in previously treated Chinese gastric cancer patients
|
Liu, JM; Chen, LT; Chao, Y; Li, AFY; Wu, CW; Liu, TS; Shiah, HS; Chang, JY; Chen, CT; Wu, HW; Lin, WC; Lan, C; Whang-Peng, J |
| 國家衛生研究院 |
2002-02 |
Additive effect of interleukin-12 and interleukin-18 on the T-helper cell pathway of malignant pleural effusion
|
Yao, NS; Chen, YM; Perng, RP; Whang-Peng, J |
| 國家衛生研究院 |
2002-01 |
Paclitaxel plus carboplatin, compared with paclitaxel plus gemcitabine, shows similar efficacy while more cost-effective: a randomized phase II study of combination chemotherapy against inoperable non-small-cell lung cancer previously untreated
|
Chen, YM; Perng, RP; Lee, YC; Shih, JF; Lee, CS; Tsai, CM; Whang-Peng, J |
| 國家衛生研究院 |
2002 |
A phase I study of weekly docetaxel, 24-hour infusion of high-dose fluorouracil/leucovorin and cisplatin in patients with advanced gastric cancer
|
Chen, LT; Liu, TW; Wu, CW; Chung, TR; Shiah, HS; Jan, CM; Liu, JM; Whang-Peng, J; Chang, JY |
| 國家衛生研究院 |
2002 |
Phase I and pharmacokinetic studies of oral thalidomide in advanced hepatocellular carcinoma
|
Chen, LT;Chao, Y;Yao, TJ;Huang, JD;Chang, JY;Chin, YH;Chuang, TR;Reed, E;Whang-Peng, J;Liu, TW |
| 國家衛生研究院 |
2001-10 |
Efficacy of Re-188-labelled sulphur colloid on prolongation of survival time in melanoma-bearing animals
|
Chen, FD; Hsieh, BT; Wang, HE; Ou, YH; Yang, WK; Whang-Peng, J; Liu, RS; Knapp, FF; Ting, G; Yen, SH |
| 國家衛生研究院 |
2001-09-01 |
Inverted repeats as genetic elements for promoting DNA inverted duplication: implications in gene amplification
|
Lin, CT; Lin, WH; Lyu, YL; Whang-Peng, J |
| 國家衛生研究院 |
2001-08-15 |
Suppression of gene amplification and chromosomal DNA integration by the DNA mismatch repair system
|
Lin, CT; Lyu, YL; Xia, H; Lin, WH; Whang-Peng, J |
| 中國醫藥大學 |
2001-04-05 |
Differential effects of antigen loading and coordinated activation of dendritic cells by different forms of tumor cells expressing CD40 ligand.
|
(Liu, K.-J.)*; 莊聲宏(Shin-Hun Juang); (Wang, C.-C.); (Ting C.-C.); (Whang-Peng, J.) |
| 國家衛生研究院 |
2001-04 |
Interleukin-7 and interleukin-12 have different effects in rescue of depressed cellular immunity: Comparison of malignant and tuberculous pleural effusions
|
Chen, YM; Tsai, CM; Whang-Peng, J; Perng, RP |
| 國家衛生研究院 |
2001-01 |
An analysis of cytokine status in the serum and effusions of patients with tuberculous and lung cancer
|
Chen, YM; Yang, WK; Whang-Peng, J; Tsai, CM; Perng, RP |
| 國家衛生研究院 |
2000-12 |
Phase II study with gemcitabine, ifosfamide and cisplatin in advanced non-small cell lung cancer
|
Chen, YM; Perng, RP; Whang-Peng, J; Wu, HW; Lin, WC; Tsai, CM |
| 國家衛生研究院 |
2000-08 |
Phase II study of tamoxifen, ifosfamide, epirubicin and cisplatin combination chemotherapy in patients with non-small cell lung cancer failing previous chemotherapy
|
Chen, YM; Perng, RP; Yang, KY; Lin, WC; Wu, HW; Tsai, CM; Whang-Peng, J |
| 國家衛生研究院 |
2000-06 |
A multicenter phase II trial of vinorelbine plus gemcitabine in previously untreated inoperable (stage IIIB/IV) non-small cell lung cancer
|
Chen, YM; Perng, RP; Yang, KY; Liu, TW; Tsai, CM; Liu, JM; Whang-Peng, J |
| 國家衛生研究院 |
2000-05-25 |
PIK3CA as an oncogene in cervical cancer
|
Ma, YY; Wei, SJ; Lin, YC; Lung, JC; Chang, TC; Whang-Peng, J; Liu, JM; Yang, DM; Yang, WK; Shen, CY |
| 國家衛生研究院 |
2000-05 |
Development of DNA delivery system using Pseudomonas exotoxin A and a DNA binding region of human DNA topoisomerase I
|
Chen, TY; Hsu, CT; Chang, KH; Ting, CY; Whang-Peng, J; Hui, CF; Hwang, J |
| 國家衛生研究院 |
2000-05 |
Integration of computer-assembled digital images and text data as evidence for the oncological record
|
Liu, JM; Wu, HW; Chen, WS; Lin, WC; Chao, Y; Lui, WY; Whang-Peng, J |
| 國家衛生研究院 |
2000-02 |
In vitro evaluation of GL331's cancer cell killing and apoptosis-inducing activity in combination with other chemotherapeutic agents
|
Huang, TS; Shu, CH; Lee, CC; Chen, LT; Whang-Peng, J |
| 國家衛生研究院 |
2000-02 |
A phase II trial of vinorelbine and cisplatin in previously untreated inoperable non-small-cell lung cancer
|
Perng, RP; Shih, JF; Chen, YM; Delgado, FM; Tsai, CM; Chou, KC; Liu, JM; Chern, MS; Whang-Peng, J |
| 國家衛生研究院 |
2000-02 |
A phase II trial of tamoxifen, ifosfamide, epirubicin, and cisplatin combination chemotherapy for inoperable non-small-cell lung cancer
|
Chen, YM; Perng, RP; Yang, KY; Lin, WC; Wu, HW; Liu, JM; Tsai, CM; Whang-Peng, J |
| 國家衛生研究院 |
2000 |
Phase II study of docetaxel plus gemcitabine in patients with non-small cell lung cancer (NSCLC) that failed previous chemotherapy (CT)
|
Chen, YM;Perng, RP;Whang-Peng, J;Lin, WC;Wu, HW;Tsai, CM |
| 國家衛生研究院 |
1999-12 |
Depressed cytolytic activity of peripheral blood mononuclear cells in unusually high paclitaxel concentrations: Reversal by IL-2 and IL-12
|
Chen, Y;Yang, W;Ting, C;Yang, D;Whang-Peng, J;Perng, R |
| 國家衛生研究院 |
1999-11 |
The significance of body weight change in non-Hodgkins lymphoma
|
Chin, YH; Liu, JM; Tai, JJ; Chuang, MS; Ho, YL; Chen, YM; Whang-Peng, J; Cheng, AL |
| 國家衛生研究院 |
1999-09 |
Analysis of astrocytoma heterogeneity: Detection of telomere shortening, BCL-2 expression, and multiple gains and losses of genetIc material in four primary cultures of astrocytoma
|
Chen, MH;Lee, CC;Chin, CC;Whang-Peng, J;Huang, TS |
顯示項目 151-200 / 215 (共5頁)
<< < 1 2 3 4 5 > >>
每頁顯示[10|25|50]項目
|
